New Approaches to NCDs: Live Webcast July 16 from Johannesburg

New Approaches to NCDs: Live Webcast July 16 from Johannesburg

{Photo credit: MSH}Photo credit: MSH

Experts in global health and chronic diseases, policymakers, patient groups, and more, are assembling in Johannesburg, South Africa, for the second one-day event hosted by The Economist on "New Approaches to Non-Communicable Diseases" July 16. Following on a successful October 2012 meeting in Geneva, this year's theme is "Accelerating Progress in Prevention and Control." Moderated by The Economist Group editors, the discussions will focus on the rise in chronic diseases in low- and middle-income countries and on developing solutions together through innovative cross-sector partnerships. 

Gloria Sangiwa, MD, MSH's global technical lead on chronic diseases, will present at a panel on "Collaborating for change: new thinking on healthcare partnerships" at 10:40 a.m. EDT. Additional event speakers include: Peter Benjamin of mHealth Alliance (USA); Maurice Mars of University of KwaZulu-Natal (South Africa); Pooven Moodley, Oxfam (South Africa); Bart Peterson, Eli Lilly and Company (USA); and Dillon Woods, Donald Woods Foundation (USA).

Selected sessions will be webcast here. (In-person event is invitation only.) Register online now to network with others, join the conversation, and watch selected sessions (complete program here). 

Event supporters include: NCD Alliance, American Cancer Society, International Diabetes Foundation, International Union Against Tuberculosis and Lung Disease, World Heart Federation, and Union for International Cancer Control (UICC).

Join the discussion on Twitter with " href="https://twitter.com/search?q=%23econhealth&src=hash">.

Learn more about MSH's work in chronic diseases

 

 

Comments

V. Tata
This is a good topic to dwell on because sometimes the quantity/quality of care doesn't really matter unless efforts to mitigate/manage/treat diseases are deployed in sufficient amounts to the right targets at the right time and expeditiously too. This may entail detailed pre-planning (which may not always be possible because disease outbreaks don't announce their arrival). The fact is that there is the urgent need to accelerate efforts geared at prevention and control, without which efforts to eliminate and eradicate disease outbreaks end up being very costly. Expediency is even more important today because improved transportation has enhanced human mobility, but also facilitated the spread of diseases. It is no longer possible to quarantine a cohort and target for treatment because people have urgent business to conduct across the city, country or on the other side of the world and may inadvertently carry and spread diseases far and wide further complicating treatment efforts and thereby compromising global health as a whole.

Add new comment

Printer Friendly VersionPDF